Annals of Oncology

News:

WHO and six publishers launch Access to Research, internet initiative for developing countries
Ann Oncol 13: 641-645; doi:10.1093/annonc/mdf233
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Editorials:

T. M. Suter and B. Meier

Detection of anthracycline-induced cardiotoxicity: is there light at the end of the tunnel?
Ann Oncol 13: 647-649; doi:10.1093/annonc/mdf231
[Extract] [FREE Full Text] [PDF] [Request Permissions]

L. Gianni

High-dose chemotherapy for breast cancer: any use for it?
Ann Oncol 13: 650-652; doi:10.1093/annonc/mdf232
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

M. Hejna, M. Schmidinger, and M. Raderer

The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?
Ann Oncol 13: 653-668; doi:10.1093/annonc/mdf142
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. Davies, L.-A. Martin, N. Sacks, and M. Dowsett

Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention
Ann Oncol 13: 669-678; doi:10.1093/annonc/mdf125
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Breast cancer:

A. Schneeweiss, M. Hensel, P. Sinn, T. Khbeis, R. Haas, G. Bastert, and A. D. Ho

Characteristics associated with long-term progression-free survival following high-dose chemotherapy in metastatic breast cancer and influence of chemotherapy dose
Ann Oncol 13: 679-688; doi:10.1093/annonc/mdf168
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. G. Schrama, I. F. Faneyte, J. H. Schornagel, J. W. Baars, J. L. Peterse, M. J. van de Vijver, O. Dalesio, H. van Tinteren, E. J. T. Rutgers, D. J. Richel, and S. Rodenhuis

Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up
Ann Oncol 13: 689-698; doi:10.1093/annonc/mdf203
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

B. V. Jensen, T. Skovsgaard, and S. L. Nielsen

Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients
Ann Oncol 13: 699-709; doi:10.1093/annonc/mdf132
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

D. Cardinale, M. T. Sandri, A. Martinoni, E. Borghini, M. Civelli, G. Lamantia, S. Cinieri, G. Martinelli, C. Fiorentini, and C. M. Cipolla

Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy
Ann Oncol 13: 710-715; doi:10.1093/annonc/mdf170
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gastrointestinal tumors:

S. Cascinu, F. Graziano, F. Ferraù, V. Catalano, C. Massacesi, D. Santini, R. R. Silva, S. Barni, A. Zaniboni, N. Battelli, S. Siena, P. Giordani, D. Mari, A. M. Baldelli, S. Antognoli, R. Maisano, D. Priolo, M. A. Pessi, G. Tonini, S. Rota, and R. Labianca

Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD)
Ann Oncol 13: 716-720; doi:10.1093/annonc/mdf091
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

T. Conroy, P.-L. Etienne, A. Adenis, M. Ducreux, B. Paillot, J. Oliveira, J.-F. Seitz, E. Francois, E. Van Cutsem, D. J. T. Wagener, F. Kohser, S. Daamen, M. Praet, T. Gorlia, B. Baron, and J. Wils

Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival
Ann Oncol 13: 721-729; doi:10.1093/annonc/mdf063
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

J. Feliu, J. Calvillo, A. Escribano, J. de Castro, M. E. Sánchez, A. Mata, E. Espinosa, A. García Grande, A. Mateo, and M. González Barón

Neoadjuvant therapy of rectal carcinoma with UFT–leucovorin plus radiotherapy
Ann Oncol 13: 730-736; doi:10.1093/annonc/mdf116
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Lung cancer:

S. J. Clarke, R. Abratt, L. Goedhals, M. J. Boyer, M. J. Millward, and S. P. Ackland

Phase II trial of pemetrexed disodium (ALIMTA^®, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer
Ann Oncol 13: 737-741; doi:10.1093/annonc/mdf115
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. Pérol, H. Léna, P. Thomas, G. Robinet, P. Fournel, E Coste, C. Belleguic, H. Le Caer, F. Blanchon, A. Vergnenègre, J.-M Vernejoux, M.-P. Schuller-Lebeau, and E. Pham

Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin–vinorelbine with a cisplatin–vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study
Ann Oncol 13: 742-747; doi:10.1093/annonc/mdf128
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

R. Arriagada, T. Le Chevalier, A. Rivière, P. Chomy, I. Monnet, E. Bardet, J. A Santos-Miranda, C. Le Péchoux, M. Tarayre, S. Benhamou, and A. Laplanche

Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients
Ann Oncol 13: 748-754; doi:10.1093/annonc/mdf123
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I and pharmacokinetics:

F. Mayer, J. T. Hartmann, J. von Pawel, J. Beck, M. Schroeder, I. Boehlke, L. Kanz, and C. Bokemeyer

A phase I study of oral uracil–ftorafur plus folinic acid in combination with weekly paclitaxel in patients with solid tumors
Ann Oncol 13: 755-759; doi:10.1093/annonc/mdf129
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

E. Cellarier, C. Terret, P. Labarre, R. Ouabdesselam, H. Curé, C. Marchenay, J. C. Maurizis, J. C. Madelmont, P. Chollet, and J. P. Armand

Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patients
Ann Oncol 13: 760-769; doi:10.1093/annonc/mdf098
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. A. Rosenthal, D. Rischin, G. McArthur, K. Ribbons, B. Chong, J. Fareed, G. Toner, M. D. Green, and R. L. Basser

Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia
Ann Oncol 13: 770-776; doi:10.1093/annonc/mdf117
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Miscellaneous tumors:

C. Twelves, M. Campone, B. Coudert, M. Van den Bent, M. de Jonge, C. Dittrich, R. Rampling, R. Sorio, D. Lacombe, C. de Balincourt, and P. Fumoleau

Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme
Ann Oncol 13: 777-780; doi:10.1093/annonc/mdf121
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic Malignancies:

W.-I. Lee, H. Kantarjian, A. Glassman, M. Talpaz, and M.-S. Lee

Quantitative measurement of BCR/abl transcripts using real-time polymerase chain reaction
Ann Oncol 13: 781-788; doi:10.1093/annonc/mdf156
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. Patte, C. Sakiroglu, S. Ansoborlo, A. Baruchel, E. Plouvier, H. Pacquement, and A. Babin-Boilletot

Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d’Oncologie Pédiatrique LMB89 protocol
Ann Oncol 13: 789-795; doi:10.1093/annonc/mdf134
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Clinical cases:

N. Frickhofen, F.-J. Beck, B. Jung, H.-G. Fuhr, H. Andrasch, and M. Sigmund

Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil
Ann Oncol 13: 797-801; doi:10.1093/annonc/mdf035
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Trojan, M. Jermann, C. Taverna, and T. F. Hany

Fusion PET–CT imaging of neurolymphomatosis
Ann Oncol 13: 802-805; doi:10.1093/annonc/mdf057
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

J. Rudi

Chemotherapy with gemcitabine in patients with gall-bladder carcinoma
Ann Oncol 13: 807; doi:10.1093/annonc/mdf162
[Extract] [FREE Full Text] [PDF] [Request Permissions]

V. Medina Arana, Y. Barrios del Pino, C. García-Castro, J. J. González-Aguilera, A. Fernández-Peralta, and F. González Hermoso

Highly aggressive leiomyosarcoma associated with Lynch II syndrome: increasing the range of extracolonic cancers related with hereditary non-polyposis colonic cancer
Ann Oncol 13: 807-808; doi:10.1093/annonc/mdf163
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Book reviews:

D. Schrijvers

D. Jeffrey (ed). Teaching Palliative Care: A Practical Guide
Ann Oncol 13: 809; doi:10.1093/annonc/mdf141
[Extract] [FREE Full Text] [PDF] [Request Permissions]

D. Fink

S.C. Rubin, G.P. Sutton (eds).Ovarian Cancer
Ann Oncol 13: 809-810; doi:10.1093/annonc/mdf140
[Extract] [FREE Full Text] [PDF] [Request Permissions]

M. Bendandi

S.A. Brooks, U. Schumacher (eds). Metastasis Research Protocols, Volumes 1 & 2
Ann Oncol 13: 810; doi:10.1093/annonc/mdf180
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.